2-acetamido-3-sulfanylpropanoic acid;(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酰胺类
• 英文名称: 2-acetamido-3-sulfanylpropanoic acid;(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
• 化学式: C21H28N4O8S2
• 分子量: 528.6
• InChiKey: GLNGYXQKTBRIEL-YWUHCJSESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.47
• 重原子数：
  35
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  226
• 氢给体数：
  7
• 氢受体数：
  11

文献信息

• MEDICAL PRODUCTS FOR USE IN CONDITIONS RELATED TO MICROBIAL INFECTIONS IN THE UPPER AERODIGESTIVE TRACT
  申请人：Härkönen Matti

  公开号：US20140128336A1

  公开（公告）日：2014-05-08

  The present invention concerns products, such as compositions or medical devices, comprising one or more compounds of the Formula I, containing one or more free sulphhydryl groups, where R 1 is hydrogen or an acetyl group, and R 2 is a sulphhydryl group or a C1-C5 straight chained or branched hydrocarbon chain, optionally containing one or more heteroatoms selected from O, N and S, further containing one or more free sulphhydryl groups, for use in connection with Helicobacter pylori infections or other related infections, either as such or as combinations with antibiotics, whereby the compound(s) and optionally, when present, the antibiotic(s), are mixed with one or more pharmaceutically acceptable carriers providing sustained local release in the stomach or elsewhere in the upper aerodigestive tract.